Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A BURGER

Showing results (1-10 of 1,155) with videos related to

Pageof 116
Sort By:
Journal of Medicinal Chemistry|January 1, 1978
Drug design and development. A realistic appraisalA Burger
Arzneimittel-Forschung|January 1, 1975
Dissolution and polymorphism of metolazoneA Burger
Current Hematologic Malignancy Reports|December 21, 2013
Bruton's tyrosine kinase (BTK) inhibitors in clinical trialsJan A Burger
Journal of Gynecologic Oncology|April 10, 2010
Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignanciesRobert A Burger
Blood|June 15, 2013
Osteopontin: an unhealthy sleep remedy for ALLJan A Burger
Hematology. American Society of Hematology. Education Program|December 14, 2011
Nurture versus nature: the microenvironment in chronic lymphocytic leukemiaJan A Burger
Gynecologic Oncology|January 11, 2011
Overview of anti-angiogenic agents in development for ovarian cancerRobert A Burger
Seminars in Cancer Biology|October 2, 2010
Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): from understanding the basics towards therapeutic targetingJan A Burger
Methods in Molecular Biology (Clifton, N.J.)|April 3, 2013
The use of the MegaBACE for sequencing and genotype analysisPamela A Burger
Cancer Journal (Sudbury, Mass.)|November 26, 2019
Bruton Tyrosine Kinase Inhibitors: Present and FutureJan A Burger
Pageof 116

Showing results (1-10 of 1,155) with videos related to

Sort By:
Pageof 116
Journal of Medicinal Chemistry|January 1, 1978
Drug design and development. A realistic appraisalA Burger
Arzneimittel-Forschung|January 1, 1975
Dissolution and polymorphism of metolazoneA Burger
Current Hematologic Malignancy Reports|December 21, 2013
Bruton's tyrosine kinase (BTK) inhibitors in clinical trialsJan A Burger
Journal of Gynecologic Oncology|April 10, 2010
Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignanciesRobert A Burger
Blood|June 15, 2013
Osteopontin: an unhealthy sleep remedy for ALLJan A Burger
Hematology. American Society of Hematology. Education Program|December 14, 2011
Nurture versus nature: the microenvironment in chronic lymphocytic leukemiaJan A Burger
Gynecologic Oncology|January 11, 2011
Overview of anti-angiogenic agents in development for ovarian cancerRobert A Burger
Seminars in Cancer Biology|October 2, 2010
Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): from understanding the basics towards therapeutic targetingJan A Burger
Methods in Molecular Biology (Clifton, N.J.)|April 3, 2013
The use of the MegaBACE for sequencing and genotype analysisPamela A Burger
Cancer Journal (Sudbury, Mass.)|November 26, 2019
Bruton Tyrosine Kinase Inhibitors: Present and FutureJan A Burger
Pageof 116